- Home
- Products
- Customized FluoroAb™
- EDNRB
- Anti-EDNRB MAb (Clone 1)-iFluor® 350 Succinimidyl Ester
Anti-EDNRB MAb (Clone 1)-iFluor® 350 Succinimidyl Ester (CAT#: WJY0-LS513)
- TARGET
- ANTIBODY
- DYE
- Name
- EDNRB
- Alternative Names
- EDNRB; Endothelin receptor type B
- Overview
- Humanized Anti-EDNRB Antibody (Clone 1)
- Species Reactivity
- Human
- Name
- iFluor® 350 Succinimidyl Ester
- Color
- Blue
- Excitation⁄Emission (nm)
- 345/450
- Detection method
- Fluorescent
Published Data
+ Submit Publications
Scientific Resources
Customer Reviews and FAQs
There are currently no Customer reviews or questions for WJY0-LS513. Click the button above to contact us or submit your feedback about this product.
Quick Links
Other Products
Same Target
| CAT# | Product Name | Linker | Payload |
| ADC-W-565 | Anti-EDNRB-VC-MMAE ADC | VC (valine-citrulline) | MMAE (Monomethyl auristatin E) |
| ADC-W-536 | Anti-EDNRB (endothelin B)-VC-MMAE ADC | VC (valine-citrulline) | MMAE (Monomethyl auristatin E) |
| ADC-W-601 | Anti-EDNBR-VC-MMAE ADC-1 | VC (valine-citrulline) | MMAE (Monomethyl auristatin E) |
For Research Use Only. NOT FOR CLINICAL USE.
Related Products
- Anti-CD6 MAb (Clone 14)-iFluor® 350 Succinimidyl Ester (CAT#: WJY0-LS1215)
- Anti-CD70 MAb (Clone 5)-iFluor® 546 Succinimidyl Ester (CAT#: WJY0-LS14258)
- Anti-IGHE MAb (Clone 9)-iFluor® 532 Succinimidyl Ester (CAT#: WJY0-LS13605)
- Anti-OxLDL MAb (Clone 1)-iFluor® 430 Succinimidyl Ester (CAT#: WJY0-LS3819)
- Anti-ERBB2 MAb (Clone 11)-iFluor® 555 Succinimidyl Ester (CAT#: WJY0-LS15744)
- Anti-FGFR2 MAb (Clone 1)-iFluor® 546 Succinimidyl Ester (CAT#: WJY0-LS14093)
- Anti-CD28 MAb (Clone 7)-iFluor® 440 Succinimidyl Ester (CAT#: WJY0-LS6244)
- Anti-CD22 MAb (Clone 13)-iFluor® 514 Succinimidyl Ester (CAT#: WJY0-LS11172)
- Anti-CD4 MAb (Clone 16)-iFluor® 555 Succinimidyl Ester (CAT#: WJY0-LS16529)
- Anti-CD70 MAb (Clone 3)-iFluor® 514 Succinimidyl Ester (CAT#: WJY0-LS11180)
Online Inquiry
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.